Canada - Re-Export of Vaccines for Human Use
Since 2014, Canada Re-Export of Vaccines for Human Use decreased by 34.5% year on year. With $5,899,414 in 2019, the country was ranked number 3 comparing other countries in Re-Export of Vaccines for Human Use. Canada is overtaken by United Arab Emirates, which was ranked number 2 at $7,990,507.15 and is followed by Saudi Arabia with $2,820,037. United States topped the ranking with $21,386,560.62 in 2019, that is a fall of 18% versus 2018. Guyana recorded the best 5 years average growth at +106.5% per year, while Trinidad and Tobago recorded the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 5,899,414.00 |
| 2018 | 1,285,278.88 |
| 2017 | 1,343,058.38 |
| 2016 | 32,054,558.00 |
| 2015 | 48,423,228.00 |
Download all data from 2004 to 2019
How does Canada rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data |
| 3 |
#3
Canada
|
5,899,414.00 | 2019 | +359.0 % | -34.5 % | View data |
| 4 |
#4
Saudi Arabia
|
2,820,037.00 | 2018 | NA | NA | View data |
| 5 |
#5
Kuwait
|
837,476.63 | 2017 | NA | NA | View data |